Most Cited Papers In Last Two Years

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma

Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies

Anti-BCMA novel therapies for multiple myeloma

Immune checkpoint inhibitors in ovarian cancer: where do we go from here?

Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Emerging roles of 3D-culture systems in tackling tumor drug resistance

Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance

Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

Nano-TRAIL: a promising path to cancer therapy

Supramolecular host-guest nanosystems for overcoming cancer drug resistance

Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance

New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collection

Targeting regulated cell death pathways in acute myeloid leukemia

Unlocking antitumor immunity with adenosine receptor blockers